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Purpose: Total knee replacement is one of the most painful orthopedic procedures, 
and effective pain relief is essential for early mobility and discharge from hospital. 
The aim of this study was to evaluate whether addition of single-injection femoral 
nerve block to epidural analgesia would provide better postoperative pain control, 
compared to epidural analgesia alone, after total knee replacement. Materials and 
Methods: Thirty-eight patients received a single-injection femoral nerve block with 
0.25% levobupivacaine (30 mL) combined with epidural analgesia (femoral nerve 
block group) and 40 patients received epidural analgesia alone (control group). Pain 
intensity and volume of patient-controlled epidural analgesia medication and rescue 
analgesic requirements were measured in the first 48 hours after surgery at three 
time periods; 0-6 hours, 6-24 hours, and 24-48 hours. Also, side effects such as nau-
sea, vomiting, and pruritus were evaluated. Results: Median visual analog scale at 
rest and movement was significantly lower until 48 hours in the femoral nerve 
block group. Patient-controlled epidural analgesia volume was significantly lower 
throughout the study period, however, rescue analgesia requirements were signifi-
cantly lower only up to 6 hours in the femoral nerve block group. The incidences of 
nausea and vomiting and rescue antiemetic requirement were significantly lower in 
the femoral nerve block group up to 6 hours. Conclusion: The combination of fem-
oral nerve block with epidural analgesia is an effective pain management regimen 
in patients undergoing unilateral total knee replacement. 
Key Words:    Femoral nerve block, patient-controlled epidural analgesia, total 
knee replacement, visual analog scale
INTRODUCTION
Total knee replacement (TKR) is one of the most painful orthopedic procedures, 
mandating effective postoperative pain management. Epidural analgesia is widely 
used in patients undergoing TKR because of effective pain relief and better reha-Ae-Ryung Lee, et al.
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ing directed downward. Immediately after spinal anesthe-
sia, a 19-gauge epidural catheter with a single open end 
hole (FlexTipPlus®, Arrow International, Inc., PA, USA) 
was inserted via 17-gauge Tuohy needle at the L3-4 or 
L4-5 interspaces using the loss-of-resistance technique to 
air. The catheter was advanced approximately 3-5 cm into 
the epidural space with the bevel of the Tuohy needle di-
rected cephalad. After epidural catheter insertion, patients 
were laid on their back, and the epidural catheter was eval-
uated to exclude inadvertent intrathecal or intravascular 
placement by aspiration from the catheter and by adminis-
tering 3 mL of 2% lidocaine containing 5 μg/mL of epi-
nephrine. At thirty minutes before the end of the surgery, 
0.2% ropivacaine (10 mL) was administered via epidural 
catheter. Immediately, before the end of the surgery, ondan-
setron (4 mg) was administered intravenously as a prophy-
lactic measure for PONV. After the surgery, patients were 
transferred to the postanesthesia care unit (PACU). Patients 
and treating clinicians were not blinded as to study group 
randomization. In FNB group, FNB was performed in the 
PACU after patient’s sensory blockade regressed to below 
T11 and initial recovery of motor function. A 5 cm, 22-gauge 
insulated needle (Stimuplex; B. Braun, Melsungen, Germa-
ny) was inserted lateral to the femoral pulse at the level of 
the inguinal crease. 0.25% Levobupivacaine (30 mL) with 
5 μg/mL epinephrine was injected after eliciting a quadri-
ceps contraction at 0.4 mAmp (not at 0.2 mAmp). The quali-
ty of initial femoral block was assessed by the loss of pin-
prick sensation over the mid-anterior thigh at 30 min after 
the block. Patients remained in the PACU for two hours.
Patient-controlled epidural analgesia (PCEA) device 
(APM Abbott; Chicago, IL, USA) was connected to epidur-
al catheter, and infusion was started when sensory level 
dropped below T12. PCEA regimen comprised 0.2% ropi-
vacaine plus fentanyl 3 μg/mL, and PCEA device was ini-
tially programmed to deliver at 4 mL/h basal rate, 3 mL bo-
lus dose, with lock-out duration of 10 min. The acute pain 
service modified infusion rate according to patient’s pain 
level and side effects.
Anesthesiologist who visited patients during the postop-
erative period was not aware of patients’ assignments. All 
patients received oxygen (5 L/min) via a facial mask for at 
least 24 hour after surgery. Pain intensity scores, occurrenc-
es of nausea, vomiting, and pruritus, PCEA consumption, 
supplementary meperidine, respiratory rate, sedation score, 
SpO2, and blood pressure were monitored in the first 48 
hours after the end of surgery at 3 time periods; 0 to 6 hours, 
bilitation profiles than other postoperative analgesic modal-
ities.1,2 In our hospital, however, epidural analgesia alone 
often failed to provide adequate postoperative pain control, 
especially on the first postoperative day, and patients fre-
quently demanded rescue analgesics (i.e., systemic opioids) 
for break-through pain relief. 
Recently, femoral nerve block (FNB) demonstrated ef-
fective postoperative pain control in the lower extremity 
surgeries.3-8 Therefore, on the basis of epidural analgesia as 
a part of multimodal approach to perioperative pain man-
agement, we hypothesized that addition of single-injection 
FNB with a typical duration of analgesic effect for 24 hours7 
may improve the quality of pain relief, decrease epidural-
related side effects, and increase patients’ satisfaction dur-
ing immediate postoperative periods. Therefore, the aim of 
this study was to evaluate whether addition of single-injec-
tion FNB to epidural analgesia would provide better post-
operative pain control, compared to epidural analgesia alone, 
in patients undergoing unilateral TKR. 
MATERIALS AND METHODS
The institutional review board approved this study and all 
patients provided written informed consent. Eighty patients 
undergoing unilateral TKR were included in this prospec-
tive, randomized trial. 
Exclusion criteria included TKR, study drugs allergy, 
opioid dependence, history of previous postoperative nau-
sea, vomiting (PONV) and motion sickness, contraindica-
tion for epidural block (previous back surgery, bleeding di-
athesis, and neurologic dysfunction), contraindication to 
FNB (infection at injection site), inability to use the PCEA 
device and comprehend the visual analog scale (VAS) for 
pain assessment, or unwillingness to be enrolled in the study. 
Using a sealed envelope technique, patients were ran-
domly allocated into: FNB + epidural analgesia group 
(FNB group, n = 40) or epidural analgesia-only group (con-
trol group, n = 40). No premedication was given in all pa-
tients. All patients received standard monitoring and care 
for combined spinal-epidural (CSE) anesthesia (two-stage 
method). For spinal anesthesia, patients were placed in lat-
eral decubitus position (operating side down), and dural 
puncture was performed at the L3-4 or L4-5 level with a 
25-gauge Whitacre spinal needle after local anesthesia. Af-
ter return of clear, free-flowing cerebrospinal fluid, 8 to 10 
mg of 0.5% bupivacaine was injected with Whitacre open-Femoral Nerve Block and Epidural Analgesia 
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each group were enrolled (40 patients in each group). 
Data are presented as mean ± SD for continuous values 
or median with interquartile range for discontinuous values. 
For continuous variables, Student’s t test or Mann-Whitney 
rank sum test was employed to compare the inter-group dif-
ference, and Chi-square test or Fisher exact test was adopt-
ed for categorical variables. The difference was regarded as 
statistically significant when the p < 0.05.
RESULTS
Two patients in the FNB group were excluded because of 
accidental epidural catheter removal on POD 1. The results 
were analyzed using 38 and 40 patients in the FNB and 
control groups, respectively. Patients’ characteristics and 
operative data between two groups were similar. Patient’s 
satisfaction at 48 hours after surgery was significantly high-
er in FNB group (Table 1). The number of patients with VAS 
scores ≥ 50 at rest was significantly fewer in the FNB group 
than the control group: 0 vs. 17 (43%); p < 0.001, 4 (11%) 
vs. 25 (63%); p < 0.001 and 5 (13%) vs. 14 (35%); p = 0.025 
during 0-6 hours, 6-24 hours, and 24-48 hours, respectively. 
As measured by the VAS, patients in the FNB group had sig-
nificantly less pain at rest and movement for 48 hours after 
the surgery (Fig. 1). The volume of PCEA in each time peri-
od was significantly less in the FNB group than the control 
group (Fig. 2). The supplementary meperidine was required 
in 6 (16%) vs. 18 (45%), 17 (45%) vs. 24 (60%), and 22 
(58%) vs. 15 (38%) patients during 0-6 hours, 6-24 hours, 
and 24-48 hours periods in the FNB and control groups, re-
6 to 24 hours, and 24 to 48 hours. Pain intensity scores at 
rest and movement (flexion of knee) were measured on a 
visual analog scale (VAS) at every 6 hours that ranged from 
0 mm (no pain) to 100 mm (worst pain imaginable). The 
highest VAS within each 3 time period was selected to 
make comparisons between two groups. Patients were al-
lowed to receive meperidine (50 mg) IV if they complained 
of pain ≥ 50 mm on VAS at rest. Rescue medications were 
ondansetron (4 mg) IV and chlorophenyramine (4 mg) IV 
for nausea and pruritus, respectively, and were administered 
upon patient’s request. Sedation was assessed using Ram-
say sedation scale (RSS) (1 = anxious and agitated or rest-
less, or both, 2 = cooperative, oriented, and tranquil, 3 = re-
sponding to commands only, 4 = brisk response to light 
glabellar tap, 5 = sluggish response to light glabellar tap, 6 
= no response to light glabellar tap). Rescue medications 
were naloxone (0.08 mg) IV every 5 min for respiratory 
frequency < 8 / min and Ramsay sedation scale ≥ 5.
 
Statistics
The sample size was determined based on the ability to de-
tect a difference in the primary outcome variable, and pain 
score was assessed with VAS. With 38 patients in each 
group, there was 80% power and 0.05 probability to detect 
a 30% difference in the number of patients with VAS scores 
≥ 50 at rest (the estimated proportions were 10% and 40% 
in the FNB and control groups, respectively). This was based 
on our pilot study of 20 patients in which on POD 1, VAS 
scores ≥ 50 at rest were observed in 2 (10%) patients in the 
FNB group vs. 8 (40%) patients in the control group. To ac-
count for the possible drop-out cases, two more patients in 
Table 1. Demographic and Surgical Characteristics of Patients
FNB group (n = 38) Control group (n = 40)
Age (yrs)   68 ± 6  70 ± 7
Gender (male/female) 3 / 35 2 / 38
Weight (kg)   64.0 ± 8.2   60.7 ± 9.3
Height (cm) 152.7 ± 6.0 152.5 ± 6.6
ASA (I / II / III) 12 / 24 / 2 8 / 30 / 2
Hypertension 22 (60%) 30 (75%)
Diabetes mellitus   5 (13%)   9 (23%)
Surgical time (min) 114 ± 22   113 ± 28
Tourniquet time (min)    92 ± 11   89 ± 17
Sensory level (Thoracic)  7 (6, 8) 7 (7, 8)
Satisfaction at 48 h (0 - 100)      80 (70, 86)*   55 (50, 60)
ASA, American Society of Anesthesiologist’s physical status, sensory level; measured at 30 minutes after spinal anesthesia. 
Values are expressed as mean ± standard deviation, number of patients or median (interquartile range). 
*p < 0.05 compared with the control group.Ae-Ryung Lee, et al.
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than with the control group, and these parameters were 
comparable thereafter. The incidences of pruritus and res-
cue antipruritic demands were similar between two groups. 
At 6 hours after surgery, 17 patients in the FNB group 
showed sensory evidence of a femoral nerve block, and at 
24 hours, no patient in the FNB group had sensory evi-
dence of a femoral nerve block. The presence of quadriceps 
buckling on standing was not evaluated on POD 1, because 
patients were allowed to stand and/or ambulate on POD 2 
in our institution. No patient in both groups demonstrated 
quadriceps buckling on standing on POD 2. 
There was no case of respiratory depression marked by 
respiratory rate < 8 /min or SpO2 below 90% during the 
postoperative periods in both groups. All of patients showed 
RSS 2 (cooperative, oriented, and tranquil). The significant-
ly more patients in the control group complained of dizzi-
ness compared with the ones in the FNB group during 0-6 
hours and 6-24 hours period (11 vs. 2 patients; p = 0.008 
and 8 vs. 1; p = 0.018, respectively). The incidences of 
headache and back pain were similar between two groups. 
The serial changes in blood pressures (systolic/diastolic ± 
SD) were comparable between two groups: 127/75 ± 9/7 vs. 
122/71 ± 15/9 mmHg; 128/74 ± 12/12 vs. 124/71 ± 12/8 
mmHg; 125/71 ± 13/4 vs. 124/69 ± 14/11 mmHg and 
124/62 ±10/8 vs. 125/69 ± 10/6 mmHg at preoperative peri-
od and during 0-6 hours, 6-24 hours, and 24-48 hours, respec-
tively. Severe hypotension (systolic blood pressure less than 
80 mmHg) and cardiac complications were not observed in 
both groups. No patient required naloxone. No postdural 
puncture headache or residual neurological complications 
such as numbness, dysesthesia, or weakness associated with 
FNB or combined spinal-epidural blockade were reported 
until the end of the study period. 
DISCUSSION
The single-injection FNB combined with epidural analgesia 
provided significant pain relief at rest and upon movement 
during postoperative 48 hours with concomitant decrease in 
the incidences of side effects such as nausea and vomiting 
in the early postoperative period. This might most likely 
due to significantly decreased volume of epidural PCEA 
medication compared to epidural-only group. 
Recently, intraoperative regional anesthesia and postopera-
tive epidural analgesia have been used in orthopedic surger-
ies and reported to expedite the achievements in postopera-
spectively. Significantly fewer patients in the FNB group re-
quired supplementary meperidine during the 0-6 hour peri-
od (p = 0.005). Incidences of nausea [7 (18%) vs. 16 (40%); 
p < 0.001], vomiting [1 (3%) vs. 7 (18%); p = 0.033] and res-
cue antiemetic demand [7 (18%) vs. 16 (40%); p = 0.037] at 
0-6 hour period were significantly lower in the FNB group 
Fig. 1. Temporal pain visual analog scale (VAS) at rest and with movement 
(flexion of knee). The box depicts the 25th and 75th percentiles. Horizontal 
lines represent the median (50th percentile), and bars depict the 10th and 
the 90th percentiles. *p < 0.05 compared with the control group.
100
80
60
40
20
0
6 h 24 h 48 h
V
A
S
 
(
r
e
s
t
)
*
*
*
  FNB group      Control group
100
80
60
40
20
0
6 h 24 h 48 h
V
A
S
 
(
m
o
v
e
m
e
n
t
)
*
* *
Fig. 2. Volume of patient-controlled epidural analgesia medication. Values 
are expressed as mean ± standard deviation. *p < 0.05 compared with the 
control group. PCEA, patient-controlled epidural analgesia.
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after the surgery compared with the control group. More-
over, there was significantly fewer number of patients with 
VAS scores ≥ 50 at rest in the FNB group compared with 
the control group; 0 vs. 17 (43%) and 4 (11%) vs. 25 (63%) 
during 0-6 hours and 6-24 hours, respectively. Furthermore, 
as anticipated, less PCEA-related side effects were observed 
overall in the FNB group with significant reduction in the 
incidences of nausea and vomiing during the first 6 hours 
after surgery and decreased incidence of dizziness until 24 
hours after surgery in the FNB group. This may be ascribed 
to significantly less volume of PCEA in the FNB group. 
The limitations of our study include the issue of non-
blinding, which increases risk of bias. The attempt of FNB 
using normal saline in the control group, as would be re-
quired for a truly blinded study, was considered inappropri-
ately invasive with possible risk of infection and nerve inju-
ry, therefore, unethical. We did not measure the quadriceps 
weakness on standing and rehabilitation functional mile-
stones, because, the patient ambulation and the passive 
flexion exercise begin on POD 2 in our institution, usually 
beyond 24 hours after the surgery, and, the effect of FNB is 
usually worn off by that time. The side effects of nausea, 
vomiting, and pruritus were measured in incidences rather 
than their levels of severity. It would have been substantial-
ly different for patients if they were slightly or severely in-
fluenced by nausea or pruritus. Further studies to clarify 
these issues are warranted. 
In conclusion, the multimodal approach, comprising 
combined spinal-epidural anesthesia, epidural analgesia, 
and single-injection FNB, may be considered as a compre-
hensive postoperative pain management regimen in patients 
who undergo unilateral TKR. 
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